Indication: Advanced Solid Tumors
An Open-Label Study of ALPN-202 in Subjects with Advanced Malignancies (NEON-1)
Sub-indication: Miscellaneous Malignancies
Study Type: Drug Study
Principal Investigator: Jaspreet Grewal, M.D.Norton Cancer Institute
Sponsor: Sponsor: Alpine Immune Sciences, Inc.
Learn more at ClinicalTrials.gov
Email for more information: MISC-NCIResearch@Nortonhealthcare.org
